Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bleomycin salvage therapy in NHL
NCT00003110Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Jul 1997
- Primary completion
- Aug 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bleomycin in non-Hodgkin lymphoma (NHL), sponsored by Case Comprehensive Cancer Center. Started Jul 1997; status: completed.
02
Drugs
bleomycin
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00003110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003110.